Market Place
Sourcing Support
FDA Confirms Para IV Patent for Tasimelteon (Hetlioz LQ) Oral Suspension
17 May 2024 //
FDA
FDA denies hearing to Vanda on jet lag indication for sleep disorder drug
06 Mar 2024 //
ENDPTS
Vanda takes issue with FDA`s relay of deficiencies for new Hetlioz indication
05 Feb 2024 //
ENDPTS
Vanda Pharmaceuticals Responds to Ruling in HETLIOZ® ANDA Appeal
10 May 2023 //
PR NEWSWIRE
Vanda Prevails in Jet Lag Litigation Against the FDA
29 Mar 2023 //
PR NEWSWIRE
MSN`s Generic Tasimelteon Receives Approval in the U.S.
12 Jan 2023 //
FDA
Apotex`s Generic Tasimelteon Receives Approval in the U.S.
20 Dec 2022 //
FDA
Teva, Apotex prevail over Vanda in patent infringement case
15 Dec 2022 //
FIERCEPHARMA
Teva`s Generic Tasimelteon Receives Approval in the U.S.
12 Dec 2022 //
FDA
CDER strikes back at Vanda, discloses rationale behind 2019 sNDA rejection
10 Oct 2022 //
ENDPTS
Vanda Announces Notice of Opportunity For An FDA Hearing on the sNDA
07 Sep 2022 //
PRNEWSWIRE
Vanda takes FDA to court again, seeking more info on a rejection letter
12 Apr 2022 //
ENDPTS
Vanda takes FDA to court again, seeking more info on a rejection letter
11 Apr 2022 //
ENDPTS
Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN
14 Jan 2022 //
PRNEWSWIRE
FDA Approves HETLIOZ® (tasimelteon) for Sleep Disturbances
01 Dec 2020 //
PRNEWSWIRE
FDA Accepts and Grants Priority Review of Vanda`s Applications for HETLIOZ®
03 Aug 2020 //
PRNEWSWIRE
Vanda Announces Agreement with FDA on of the Application for HETLIOZ®
13 May 2020 //
PRNEWSWIRE
Apotex`s Generic Tasimelteon Receive Tentative Approval in U.S
06 Feb 2020 //
FDA
Vanda Pharmaceuticals “perplexed” by FDA rejection of jet lag drug
22 Aug 2019 //
PHARMAPHORUM
Vanda Announces Listing of a New HETLIOZ® Patent in the FDA Orange Book
20 Sep 2018 //
PR NEWSWIRE
Hetlioz®(Tasimelteon): Vanda Pharmaceuticals v. Apotex
07 May 2018 //
PATENT LITIGATION
Hetlioz®(Tasimelteon): Vanda Pharmaceuticals v. MSN Pharmaceuticals Inc
07 May 2018 //
PATENT LITIGATION
Vanda Pharmaceuticals’ Hetlioz Shows Promise for Treating Jet Lag
05 Mar 2018 //
BIOSPACE
HETLIOZ is Now Available for the Treatment of Non-24-Hour Sleep-Wake Disorder
01 Aug 2016 //
PR NEWSWIRE
New Drug Ads Tout Serious Conditions, Costly Treatments
17 Feb 2016 //
WSJ
Vanda to receive US patent for Hetlioz
07 Jul 2015 //
PHARMABIZ
FDA Mistakenly Widened the Market for a Rare Sleep Disorder Drug: Petition
12 Jun 2015 //
PHARMALOT
BMS` Opdivo backed as melanoma therapy in EU
27 Apr 2015 //
PM LIVE
Eleven Medicines Leap Closer To Approval In Europe
26 Apr 2015 //
PHARMATIMES
First EU treatment for rare sleep-wake disorder
24 Apr 2015 //
EMA
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.